Addiction

Article	Citations
Issue Information	181
Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling	161
An Addiction series on regional perspectives on addiction‐related problems	157
	104
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	95
Commentary on Lange et al.: Acute alcohol use before suicide—is it contributing to an increase in suicide rates in the United States?	89
National profile on substance use, substance use‐related problems and policy: The case of Chile	89
	77
Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents	77
Society for the Study of Addiction Annual Conference 2024	77
Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study	76
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	74
Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data	73
The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol	69
Rare but relevant series	69
Recent decline in Chinese alcohol production and consumption: Potential contributing factors and the role of globally recommended measures	66
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	63
Austin Bradford Hill’s ‘Environment and disease: Association or causation’	60
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	59
Cannabis: Global Histories by Lucas Richert and James H. Mills, editors	57
Education matters: longitudinal pathways to mid‐life heavy drinking in a national cohort of black Americans	57
How substance use prevention research gets used in United States federal policy	57
Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	53
Naloxone administration—no balance without titration	53
Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	51

Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	50
Will Australia's tightened prescription system reduce nicotine vaping among young people?	50
Commentary on Nower et al: The Pathways Model should apply to non‐clinical gambling patterns	49
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	47
Non‐alcoholic beverage consumption among US adults who consume alcohol	46
Did the under‐reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?	44
Structure and stability of internet gaming disorder from childhood to late adolescence: A 5‐wave birth cohort study	41
Assessing the impacts of alcohol outlets on crime as a natural experiment: agglomeration, churning and spatial effects	41
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	40
Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health	40
Estimating recent trends in alcohol sales in the United Kingdom from alcohol duty revenue	40
	39
Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial	39
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	38
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	36
Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam—A 6‐year wastewater study (2018–2023)	35
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	33
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial	32
Systematic review and meta‐analyses of cytisine to support tobacco cessation	32
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	32
New Books	31
England's disposable vape ban: An inadequate solution to youth vaping with potential unintended consequences	30
Author Index	30
Issue Information	30
	29
Issue Information	28
Age‐based differences in quantity and frequency of consumption when screening for harmful alcohol use	28
Clinical alcohol guidelines are welcome—but upstream action is paramount	28
Cannabis research in context: The case for measuring and embracing regional similarities and differences	27
A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine	26
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis	26
A return on investment analysis for the 2017 increase in alcohol excise taxation in Lithuania	26
Organ pathologies detected post‐mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation‐wide 2‐year cross‐sectional study	26
	26
Drug Overdoses During the COVID‐19 Pandemic Among Recently Homeless Individuals	26
Longitudinal trajectories of marijuana use in tobacco products among young adult Texas college students from 2015 to 2019	25
Commentary on Luukkonen et al.: Policy possibilities for reducing public health harms related to pregnant people’s alcohol consumption	25
Neurophysiological error processing and addiction self‐awareness correlates of reduced insight in cannabis use disorder	25
Commentary on Lannoy et al.: The continued value of within‐family designs in addiction and psychiatric research	25
Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)	25
Identifying and describing trajectories of alcohol use frequency and binge drinking frequency among those aged 15–30 years in a national cohort of US adolescents: A group‐based trajectory modeling app	24
Commentary on Metcalfe et al.: ‘What works in AOD is when it feels like I am driving’ (Craig W, alcohol and drug peer worker)	24
Commentary on Amin‐Esmaeili et al.: Non‐abstinence outcomes in stimulant clinical trials—Why deny improvement?	24
Genetic support of a causal relationship between cannabis use and educational attainment: a two‐sample Mendelian randomization study of European ancestry	23
Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?	23
Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health	23
Perspectives on addiction‐related problems in India	23
Influence of alcohol and acetaldehyde on cognitive function: findings from an alcohol clamp study in healthy young adults	23
Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study	23
Evaluating the causal effect of tobacco smoking on white matter brain aging: a two‐sample Mendelian randomization analysis in UK Biobank	23

Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta‐analysis of prevalence and correlates	22
Commentary on Motschman et al.: Moving behavioral economic demand into the real world means moving beyond single schedules of reinforcement	22
The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid‐related deaths: findings from a modelling study	22
Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on‐line experiment	22
Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study)	22
Reducing problematic alcohol use in employees: economic evaluation of guided and unguided web‐based interventions alongside a three‐arm randomized controlled trial	22
New Books	22
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities	22
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	22
How research and policy can shape driving under the influence of cannabis	22
Effect of vaping on past‐year smoking cessation success of Australians in 2019—evidence from a national survey	22
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis	21
Deficits in general and smoking‐specific response inhibition in the Go/No‐Go task in individuals who smoke: A cross‐sectional analysis	21
Issue Information	21
Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports	21
	21
Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study	21
	21
	21
Issue Information	21
Issue Information	21
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections	20
Social genetic effects for drug use disorder among spouses	20
Drugs, Identity and Stigma. By MichelleAddison, WilliamMcGovern & RuthMcGovern. Chan, Switzerland: Palgrave Macmillan, 2022. ISBN: 9783030982867	20
Commentary on Petrilliet al.: Assessing cannabis use in real‐world settings ‐ advances using standard THC units	20
Response to Luz & Mash on cardiac toxicity of ibogaine	20
Prosecuting Poverty, Criminalizing Care. By WendyBach, Cambridge, UK: Cambridge University Press. 2022. ISBN: 9781108465533	20
New perspectives on how to formulate alcohol drinking guidelines: Response to commentaries	20
Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales	19
Combustible tobacco age‐of‐sale laws: an opportunity?	19
Changing patterns of nicotine product use and nicotine dependence among United States high‐school students: The National Youth Tobacco Survey, 2014–2023	19
‘It's not what you'd term normal smoking’: a qualitative exploration of language used to describe heated tobacco product use and associated user identity	19
The Opioid Epidemic in the United States: Missed Opportunities and Policy Failures. By Kant B.Patel & Mark E.Rushefsky, London, UK: Routledge, 2022. ISBN: 9781032105215	19
Genome‐wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci	19
Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA	19
Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals	19
The interaction of e‐cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States	19
Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis	19
Systematic review of symptom‐level networks of alcohol use disorder	18
Response to Xiao et al.: If everything is a loot box, nothing is	18
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review	18
Addiction Lives: Sir Ian Gilmore	18
Sludge, dark patterns and dark nudges: A taxonomy of online gambling platforms' deceptive design features	18
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries	18
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk	17
Support for Aboriginal health services in reducing harms from alcohol: 2‐year service provision outcomes in a cluster randomized trial	17
Issue Information	17
Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications	17
Offering e‐cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial	17
Rare but relevant: Hydrocarbons and sudden sniffing syndrome	17
How to interpret studies on the impact of legalizing cannabis	17
The advantages and downsides of online focus groups for conducting research on addictive online behaviours	17
Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects	17
Multivariable machine learning prediction of risky alcohol use in contemporary youth	17
New Books	17
Do internalising or externalising behaviours in adolescence mediate the child maltreatment‐alcohol substance use relationship?	17
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	17
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type	17
Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity	17
Commentary on Jones et al.: We must consider emergency medical services data an opportunity for a view into a community	16
Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders	16
Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?	16
Addiction Lives: Robin Davidson	16
The price of a cigarette: 20 minutes of life?	16
Challenges and opportunities for further research involving the cannabis‐to‐opioid use transition	16
Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy	16
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis	16
Validating transdermal alcohol biosensors: a meta‐analysis of associations between blood/breath‐based measures and transdermal alcohol sensor output	15
Alcohol drinking, DNA methylation and psychiatric disorders: A multi‐omics Mendelian randomization study to investigate causal pathways	15
New Books	15
Commentary on Sun and Tang: Measurement assessment and validity in problematic smartphone use	15
Stakeholders cannot simply wait for the gambling evidence‐base to develop: We must all help to build it	15
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers	15
	15
Commentary on Jackson et al.: The role of regional tobacco control in centralised nations	15
Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene	15
Effect of a workplace mobile phone‐based instant messaging intervention on smoking cessation: a cluster‐randomized controlled trial	15
Issue Information	15
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in	15
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement	15

The efficacy of an internet‐based cognitive behavioral program added to treatment‐as‐usual for alcohol‐dependent patients in primary care: a randomized controlled trial	14
Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial	14
Issue Information	14
Addressing the overdose crisis in North America with bold action	14
Yes, nitrous oxide addiction undeniably exists!	14
Commentary on Lin et al.: The importance of valid reference standards in training supervised machine learning classifiers to detect alcohol misuse	14
Issue Information	14
Issue Information	14
Functional connectivity in the central executive network predicts changes in binge drinking behavior during emerging adulthood: an observational prospective study	14
Risk of somatic disease and mortality in individuals of parents with alcohol use disorder: a register‐based cohort study	14
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022	14
Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent c	14
The geography of sobriety checkpoints and alcohol‐impaired driving	14
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study	14
	14
The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019	14
Evaluating the impact of minimum unit pricing for alcohol on road traffic accidents in Scotland after 20 months: An interrupted time series study	14
Cannabis use and sleep problems among young adults by mental health status: A prospective cohort study	14
Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada	13
Drunken snakes and sober owls: ancient authors on the relationship between animals and wine	13
Referees	13
The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia	13
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence	13
Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target	13
Addiction Lives: Viv Evans	13
Issue Information	13
Harmful compared to what? The problem of gaming and ambiguous causal questions	13
Mainstreaming smoking cessation brief advice in health systems using the United Nations human rights system	13
On the duration of cannabis effects and the presence of THC in the body	13
Changing trends in drug overdose mortality in Spain, 2001–2022	13
Understanding perceived addiction to and addictiveness of electronic cigarettes among electronic cigarette users: a cross‐sectional analysis of the International Tobacco Control Smoking and Vaping (IT	13
Commentary on Manthey et al.: No more missed opportunities—We need to address the absence of robust and comprehensive evaluations about the real‐world impact of statutory restrictions on alcoho	13
The impact of road safety policies in a deregulated alcohol tax environment in Hong Kong: a 15‐year time series analysis	13
Within‐person associations of escalated electronic nicotine delivery systems use with cigarette, alcohol, marijuana and drug use behaviors among US young adults	13
Issue Information	13
Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews	13
Commentary on Hyland et al.: Digital treatment for alcohol use disorders ‐ challenges and opportunities	13
Effect of perioperative high‐dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study	13
Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use	13
Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness an	13
The need to calibrate standardized cannabis measurements across cultures	13
Evaluation of statewide restrictions on e‐cigarette nicotine strength—United States, 2017–2022	13
Changes to our Editorial Team	13
Issue Information	13
Strategies to enhance the effects of pictorial warnings for cigarettes: results from a discrete choice experiment	12
Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies	12
Quantification of racial and ethnic disparities in alcohol‐related problems in light of different methodological approaches	12
Post‐legalization shifts in cannabis use among young adults in Georgia—A nationally representative study	12
Alcohol use disorder criteria exhibit different comorbidity patterns	12
Understanding successful policy innovation: The case of Portuguese drug policy	12
Packaging of disposable vaping products and e‐liquids in England, Canada and the United States: A content analysis	12
How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta‐analysis	12
Evaluating the effectiveness of e‐cigarettes compared with usual care for smoking cessation when offered to smokers at homeless centres: protocol for a multi‐centre cluster‐randomized controlled trial	12
Effect of 3 months and 12 months of financial incentives on 12‐month postpartum smoking cessation maintenance: A randomized controlled trial	12
How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?	12
Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study	12
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis	12
Health impacts of a scale‐up of supervised injection services in a Canadian setting: an interrupted time series analysis	12
Classifying national drinking patterns in Europe between 2000 and 2019: A clustering approach using comparable exposure data	12
Cannabis policy bundles and traffic fatalities in the American States over time	12
Predicting severe alcohol use disorders in primary care using number of heavy drinking days	12
Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?	12
	12
Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line	12
Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non‐smokers	12
Prolonged diacetylmorphine take‐home during the COVID‐19 pandemic—Results of a retrospective cohort study	12
A systematic review and meta‐analysis of factors associated with adolescent substance use in Africa, 2000 to 2020	12
Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA	12
E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study	11
Referees	11
Clinical management of psychostimulant withdrawal: review of the evidence	11
The risks of misclassifying addictive food substances as non‐addictive	11
Does a local Alcohol Health Champion programme have a measurable impact on health and crime outcomes? A natural experiment evaluation of Communities in Charge of Alcohol (CICA) based on triangulation	11
Future Directions for the International Cannabis Toolkit (iCannToolkit)	11
Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map	11
Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta‐analysis	11
Issue Information	11
Cannabis and sport: A World Anti‐Doping perspective	11
Nitrous oxide: The label ‘potentially addictive’ may do more harm than good	11
Trends and projection in the proportion of (heavy) cannabis use in Germany from 1995 to 2021	11
Will Australia's tightened prescription system reduce nicotine vaping among young people?	11
Deaths of despair	11
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review	11
When should we conduct large‐scale evaluations?	11
Let's talk about pleasure: Bridging the sociology and public health divide	11
The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic	10
	10
New Books	10
Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers	10
Changes to our Editorial Team	10
A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)‐ and psilocybin‐related death in Australia	10
The environmental impact of tobacco products: Time to increase awareness and action	10
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	10
Addiction's new Deputy Editor‐in‐Chief and Regional Editor for the Americas	10
Red Box, Green Box: Psychometric evaluation of a self‐report behavioral frequency measurement approach for behavioral addictions research	10